Edward White
Stock Analyst at HC Wainwright & Co.
(1.99)
# 2,876
Out of 4,712 analysts
349
Total ratings
29.29%
Success rate
-4.34%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.32 | - | 8 | Dec 23, 2024 | |
| PBYI Puma Biotechnology | Reiterates: Buy | $7 | $3.02 | +131.79% | 19 | Dec 23, 2024 | |
| IFRX InflaRx | Reiterates: Buy | $8 | $2.51 | +218.73% | 22 | Dec 20, 2024 | |
| ACET Adicet Bio | Reiterates: Neutral | n/a | $0.92 | - | 20 | Dec 19, 2024 | |
| LRMR Larimar Therapeutics | Reiterates: Buy | $15 | $3.78 | +296.83% | 5 | Dec 17, 2024 | |
| NYXH Nyxoah | Reiterates: Buy | $17 | $8.00 | +112.50% | 13 | Dec 13, 2024 | |
| CMRX Chimerix | Reiterates: Buy | $11 | $3.34 | +229.34% | 15 | Dec 11, 2024 | |
| CRIS Curis | Reiterates: Buy | $20 | $3.17 | +530.91% | 17 | Dec 10, 2024 | |
| SNDX Syndax Pharmaceuticals | Reiterates: Buy | $51 | $13.07 | +290.21% | 28 | Dec 10, 2024 | |
| AURA Aura Biosciences | Reiterates: Buy | $22 | $8.23 | +167.31% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.51 | - | 11 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $12.84 | +125.86% | 19 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $2.93 | +377.82% | 10 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.60 | +1,076.47% | 25 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $32.16 | +71.02% | 29 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $8.81 | - | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $12.27 | +128.20% | 21 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $5 | $2.96 | +68.92% | 9 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $20 | $4.19 | +377.33% | 30 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $4.10 | +46.35% | 13 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.45 | +780.86% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.24 | - | 12 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $2.17 | +821.66% | 4 | Jun 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.60 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.62 | +1,628.40% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $25.30 | +18.58% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.66 | +622.89% | 2 | Mar 6, 2018 |
60 Degrees Pharmaceuticals
Dec 23, 2024
Reiterates: Neutral
Price Target: n/a
Current: $1.32
Upside: -
Puma Biotechnology
Dec 23, 2024
Reiterates: Buy
Price Target: $7
Current: $3.02
Upside: +131.79%
InflaRx
Dec 20, 2024
Reiterates: Buy
Price Target: $8
Current: $2.51
Upside: +218.73%
Adicet Bio
Dec 19, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.92
Upside: -
Larimar Therapeutics
Dec 17, 2024
Reiterates: Buy
Price Target: $15
Current: $3.78
Upside: +296.83%
Nyxoah
Dec 13, 2024
Reiterates: Buy
Price Target: $17
Current: $8.00
Upside: +112.50%
Chimerix
Dec 11, 2024
Reiterates: Buy
Price Target: $11
Current: $3.34
Upside: +229.34%
Curis
Dec 10, 2024
Reiterates: Buy
Price Target: $20
Current: $3.17
Upside: +530.91%
Syndax Pharmaceuticals
Dec 10, 2024
Reiterates: Buy
Price Target: $51
Current: $13.07
Upside: +290.21%
Aura Biosciences
Nov 14, 2024
Reiterates: Buy
Price Target: $22
Current: $8.23
Upside: +167.31%
Nov 13, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.51
Upside: -
Nov 8, 2024
Reiterates: Buy
Price Target: $29
Current: $12.84
Upside: +125.86%
Nov 6, 2024
Reiterates: Buy
Price Target: $14
Current: $2.93
Upside: +377.82%
Nov 6, 2024
Reiterates: Buy
Price Target: $7
Current: $0.60
Upside: +1,076.47%
Nov 5, 2024
Maintains: Buy
Price Target: $49 → $55
Current: $32.16
Upside: +71.02%
Oct 24, 2024
Initiates: Neutral
Price Target: n/a
Current: $8.81
Upside: -
Oct 16, 2024
Reiterates: Buy
Price Target: $28
Current: $12.27
Upside: +128.20%
Oct 14, 2024
Maintains: Buy
Price Target: $15 → $5
Current: $2.96
Upside: +68.92%
Oct 11, 2024
Maintains: Buy
Price Target: $23 → $20
Current: $4.19
Upside: +377.33%
Aug 12, 2024
Reiterates: Buy
Price Target: $6
Current: $4.10
Upside: +46.35%
Aug 7, 2024
Reiterates: Buy
Price Target: $4
Current: $0.45
Upside: +780.86%
Jun 4, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.24
Upside: -
Jun 30, 2022
Maintains: Buy
Price Target: $40 → $20
Current: $2.17
Upside: +821.66%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $1.60
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $28
Current: $1.62
Upside: +1,628.40%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $25.30
Upside: +18.58%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.66
Upside: +622.89%